Skip to main content
Fig. 3 | BMC Cardiovascular Disorders

Fig. 3

From: The efficacy and safety of specific therapies for cardiac Transthyretin-mediated amyloidosis: a systematic review and meta-analysis of randomized trials

Fig. 3

A. Forest Plot for LV Longitudinal Strain. TTR-specific therapies significantly reduced LV longitudinal strain compared to placebo. Abbreviations: CI: Confidence Interval; SMD: Standardized Mean Difference; LV: Left Ventricle; TTR: Transthyretin. B. Forest Plots for LV Mass. TTR-specific therapies led to a consistent reduction in LV mass compared to placebo Abbreviations: CI: Confidence Interval; SMD: Standardized Mean Difference; LV: Left Ventricle; TTR: Transthyretin

Back to article page

BMC Cardiovascular Disorders

ISSN: 1471-2261

Contact us